ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Delignit Ag Inh O N

Delignit Ag Inh O N (DLX)

2.36
0.00
( 0.00% )
Updated: 03:06:21
Realtime Data

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
2.36
Bid
2.30
Ask
2.40
Volume
0.00
0.00 Day's Range 0.00
2.18 52 Week Range 4.20
Market Cap
Previous Close
2.36
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
3,944
Shares Outstanding
10,242,375
Dividend Yield
3.39%
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
86.18M
Net Profit
3.24M

About Delignit Ag Inh O N

Sector
Wood Products, Nec
Industry
Wood Products, Nec
Headquarters
Blomberg, Deu
Founded
-
Delignit Ag Inh O N is listed in the Wood Products sector of the Tradegate (DE) with ticker DLX. The last closing price for Delignit Ag Inh O N was 2.36 €. Over the last year, Delignit Ag Inh O N shares have traded in a share price range of 2.18 € to 4.20 €.

Delignit Ag Inh O N currently has 10,242,375 shares outstanding. The market capitalization of Delignit Ag Inh O N is 24.17 € million.

DLX Latest News

Deluxe Unveils Comprehensive Suite of Identity Theft Protection Solutions for Financial Institutions

Deluxe Provent Helps Lower Risk, Strengthen Account Holder Relationships ST. PAUL, Minn., Feb. 12 /PRNewswire-FirstCall/ -- With powerful tools to help prevent and respond to identity theft...

MerchEngines to Be Featured at Local Online Advertising Conference

CEO and founder Andy Steuer will be presenting at Borrell Associates' event NEW YORK, Feb. 8 /PRNewswire/ -- WHO: MerchEngines CEO and founder Andy Steuer will be speaking at the Borrell...

Deluxe Reports Fourth Quarter 2009 Results

- Diluted EPS of $0.59; adjusted EPS of $0.70 grows 3% vs. prior year; strong revenue at high end of outlook - Provides improved 2010 outlook; projecting strong EPS and operating cash flow...

Deluxe Enters Strategic Partnership With BancVue

REALChecking(R) to Strengthen Customer Acquisition & Retention for Deluxe Clients ST. PAUL, Minn., Jan. 12 /PRNewswire-FirstCall/ -- Deluxe Corporation (NYSE:DLX), business partner to nearly...

Deluxe Announces Earnings Release Date and Conference Call Information

- Fourth Quarter and Full-Year Financial Results and Conference Call - CJS Securities 10th Annual 'New Ideas for the New Year' Conference ST. PAUL, Minn., Jan. 6 /PRNewswire-FirstCall/ -- Deluxe...

Hostopia Solves Mass Email Migration Problems With SNAP

Innovative new technology helps service providers move email users to new platform with minimal churn SHOREVIEW, Minn., Nov. 9 /PRNewswire-FirstCall/ -- Hostopia, a business unit of Deluxe...

Deluxe Reports Third Quarter 2009 Results

- EPS of $0.56 exceeds previous outlook; adjusted EPS of $0.60 without restructuring and transaction-related costs - Increases cost reduction program to $325 million - Declares regular quarterly...

Deluxe Announces Earnings Release Date and Conference Call Information

ST. PAUL, Minn., Oct. 8 /PRNewswire-FirstCall/ -- Deluxe Corporation (NYSE:DLX) announced that it will report its 2009 third quarter results on Thursday, October 22, 2009 prior to market open...

Hostopia Launches New Email and Webmail Platform

SHOREVIEW, Minn., Sept. 29 /PRNewswire-FirstCall/ -- Hostopia, a business unit of Deluxe Corporation (NYSE:DLX), announced today that it has upgraded its 3 million email users to its latest...

Deluxe Sweepstakes Gives Small Businesses a Brand Makeover

Target Commercial Interiors, The HON Company and Deluxe for Business Offer $50,000 in Marketing Solutions and Office Furniture SHOREVIEW, Minn., Sept. 3 /PRNewswire-FirstCall/ -- Small businesses...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1002.362.382.259999912422.3338901DE
40.10000014.424783381632.25999992.42.243712.30666354DE
12-0.02-0.8403361344542.382.542.239442.35659405DE
26-1.22-34.07821229053.583.682.1845562.50911537DE
52-1.82-43.54066985654.184.22.1841843.03023306DE
156-7.74-76.633663366310.110.72.1827354.45589375DE
260-4.34-64.7761194036.7122.1828775.54145714DE

DLX - Frequently Asked Questions (FAQ)

What is the current Delignit Ag Inh O N share price?
The current share price of Delignit Ag Inh O N is 2.36 €
How many Delignit Ag Inh O N shares are in issue?
Delignit Ag Inh O N has 10,242,375 shares in issue
What is the market cap of Delignit Ag Inh O N?
The market capitalisation of Delignit Ag Inh O N is EUR 24.17M
What is the 1 year trading range for Delignit Ag Inh O N share price?
Delignit Ag Inh O N has traded in the range of 2.18 € to 4.20 € during the past year
What is the reporting currency for Delignit Ag Inh O N?
Delignit Ag Inh O N reports financial results in EUR
What is the latest annual turnover for Delignit Ag Inh O N?
The latest annual turnover of Delignit Ag Inh O N is EUR 86.18M
What is the latest annual profit for Delignit Ag Inh O N?
The latest annual profit of Delignit Ag Inh O N is EUR 3.24M
What is the registered address of Delignit Ag Inh O N?
The registered address for Delignit Ag Inh O N is K��NIGSWINKEL 2-6, BLOMBERG, 32825
What is the Delignit Ag Inh O N website address?
The website address for Delignit Ag Inh O N is www.delignit-ag.de
Which industry sector does Delignit Ag Inh O N operate in?
Delignit Ag Inh O N operates in the WOOD PRODUCTS, NEC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
H5EHelma Eigenheimbau Ag
0.12 €
(54.64%)
14.5k
SL5Recharge Resources Ltd
0.0346 €
(31.06%)
3.3k
VOPInvestigator Resources Ltd
0.017 €
(30.77%)
8.47k
23IIntraCellular Therapies Inc
116.00 €
(24.73%)
112
Y31Infinitii Ai Inc
0.068 €
(21.43%)
777.64k
KASHIntellabridge Technology Corp
0.0255 €
(-48.48%)
300
1UR1Bee Vectoring Technologies International Inc
0.003 €
(-45.45%)
169.55k
K8JBig Red Mining Corp
0.056 €
(-36.72%)
7.5k
UH7ATennant Minerals NL
0.0045 €
(-35.72%)
578
L7C2Windfall Geotek Inc
0.0055 €
(-35.29%)
1.97k
76M0Realbotix Corp
0.384 €
(-3.03%)
962.82k
Y31Infinitii Ai Inc
0.068 €
(21.43%)
777.64k
QC8AFC Energy Plc
0.1068 €
(-7.61%)
722.8k
D7GNel ASA
0.2412 €
(-1.67%)
713.47k
RQ0DWave Quantum Inc
5.046 €
(-10.34%)
626.19k

Discussion

View Full Feed
tw0122 tw0122 12 minutes ago
$4.24 target one reached 
UVIX
FranCoRazon FranCoRazon 12 minutes ago
If it was correct yes. But there are a lot of assumptions and even more details not mentioned. People get more and more fooled by AI just like google.
LWLG
Wayne R Wayne R 26 minutes ago
It's a fashion statement and ecologically friendly
Investor2014 Investor2014 30 minutes ago
Whether you like it or not, it is a fact that in May 120 days will have passed since the CHMP accepted the Anavex MAA. That will be clock stop one in the EMA process, where it is highly unlikely there will no questions raised for Anavex to reply to and for which 90 days are available.

AVXL
ducci1 ducci1 33 minutes ago
Pivot Calcs: SPX Pivot--5841----R1--5875----R2--5924-----S1--5792----S2--5758----SPY Pivot--581----R1--584----S1--576-----Vix Pivot--19.30----R1--2055----R2--21.56----R3--23.82----S1--18.29 !!LOL!!
SPY
meshcan meshcan 34 minutes ago
Nobody forcing you to stay here unless you want and you most likely are benefiting from bashing Elite or shorting or day trading...otherwise what you are saying doesn't make sense.

I know many longs here are already millionaire with current price, ~0.5 pps, but I'm sure they are waiti
ELTP
along4zride along4zride 34 minutes ago
Get ready to be thrown under (FNMA) bus .
No way no how slick suit and haircut Wall Street huckster gives one cent care about hopeful investor. More than likely common share holder has been ginned up . Sheep ready for slaughter or should I say vultures .

FNMA
jxyzobrien jxyzobrien 41 minutes ago
tangerine Mussolini
Killing the market
layoffs all over
tariff news has not yet brought in long term sellers
market should be up sunday nite NOPE
Hi_Lo Hi_Lo 50 minutes ago
Lol!! I want profits!! What you want helps me in no way!!
Exactly. Because the truth with documentation that BCAP is a scam and Jake P. Noch is a serial scammer prevents scamming pumpers and liars like you from making profits by creating bagholders here. And that's part of my goal - and to h
BCAP
DiamondHealer95 DiamondHealer95 54 minutes ago
What do you expect and how can you back your thoughts? Thanks
KBLB
DiamondHealer95 DiamondHealer95 1 hour ago
I mean Kim said once they hit 1.5 metric tons they're open for business and they're about halfway there so..... You're a genius! Congrats on the business. I also run one with 100% positive feedback over 22 years so I get the perspective🤪

Also, in my Arby's voice "I have the
KBLB
DiamondHealer95 DiamondHealer95 1 hour ago
We've invested similarly
KBLB
sunspotter sunspotter 1 hour ago
Glenn Miller’s still missing, and Emil Malak and Rich Inza are still crooks.
VPLM
Flobewan Flobewan 1 hour ago
Marc loved your ides
tinojax tinojax 1 hour ago
I usually enjoy a beer with my pizza...........I would like to know what's in the Kool Aid........
PLUG
mrfence mrfence 1 hour ago
Here we are on the cusp of the Monsta $FMCC~ $FNMA~ Gains we've all been waiting for doin da Heebie Jeebie Dance, 😃😄😁😆😅😂!
[yt]MUB3ZR4F8vw?si=Z3oB5zc_RHMtCGEY[/yt]
FMCC FNMA
IVRT IVRT 2 hours ago
In my opinion, there will likely be significant pressure on the share price leading up to the conference call. A sell-off could occur the day before, with the stock potentially bottoming out by the end of the investor call. I could be wrong, but I've seen similar patterns many times over the past 25
BMXI
DewDiligence DewDiligence 2 hours ago
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

ENTA
DewDiligence DewDiligence 2 hours ago
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

Your Recent History

Delayed Upgrade Clock